TrialInternational journal of cancer2026

Pembrolizumab-Chemotherapy Versus Pembrolizumab in Head and Neck Squamous Cell Carcinoma: A PD-L1 CPS-Stratified Analysis of Updated KEYNOTE-048 Data.

Shasha Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.